6533b857fe1ef96bd12b4566

RESEARCH PRODUCT

Racing for a SARS‐CoV‐2 vaccine

ÖZlem TüreciUgur Sahin

subject

2019-20 coronavirus outbreakMedicine (General)COVID-19 VaccinesCoronavirus disease 2019 (COVID-19)SARS-CoV-2business.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ImmunologyCOVID-19QH426-470VirologyR5-920GeneticsHumansMolecular MedicineMedicineInterviewbusiness

description

Interview with EMBO Members Özlem Türeci and Uğur Şahin, BioNTech, conducted by science journalist Kai Kupferschmidt.

10.15252/emmm.202115145https://doaj.org/article/44d2d985128940aebe823949e0467b22